Chunks with this article
Oxford AstraZeneca - Leading candidates - Vaccine for COVID19 Coronavirus

Save to folder

Choose Folders Loading...

Article Public (all visitors)

Why Oxford’s positive COVID vaccine results are puzzling scientists

NATURE 2020

Preliminary data suggest that the immunization was more effective in trial participants who received a lower dose.

View Original Source

Curated by

FoundryBase

Updated 11 months ago

ACADEMIC RESEARCH HEALTHCARE MEDICINE PHARMACEUTICAL INDUSTRY

Save

Bookmark this resource

Browse more

View all Articles

Conversation

Comments

No comments yet. Be the first to comment!

Transcription

Placed in

Chunks with this Article

1 chunk

Oxford AstraZeneca - Leading candidates - Vaccine for COVID19 Coronavirus Finding a Vaccine for COVID19 Coronavirus - leading candidates FoundryBase 5 resources

Adjacent discoveries

Related resources

Shared chunks

Resources placed near this one.

Covid Vaccine Front-Runner Is Months Ahead of Her Competition - Bloomberg (July 2020) Article • 2020 • BLOOMBERG Appears in 1 shared chunk

Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store Article • 2020 • TechCrunch Appears in 1 shared chunk

German panel advises against AstraZeneca vaccine for over-65s | Financial Times Article • 2021 • FT Appears in 1 shared chunk

USA will share millions of AstraZeneca vaccine doses worldwide - POLITICO Article • 2021 • POLITICO Appears in 1 shared chunk

Shared categories

Resources with similar topic signals.

FDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline Article • 2021 • STAT Shares 4 topic signals

Personalized Skin Cancer Vaccine Shows Promise in New Trial Results Article • 2021 • Gizmodo Shares 4 topic signals

The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race Article • 2020 • STAT Shares 4 topic signals

Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store Article • 2020 • TechCrunch Shares 4 topic signals

Moderna: Covid vaccine shows nearly 95% protection Article • 2020 • BBC News Shares 4 topic signals

Dozens of COVID-19 vaccines are in development. Here are the ones to follow - National Geographic Article • 2020 • Science Shares 4 topic signals

The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug Article • 2020 • Science | AAAS Shares 4 topic signals

Nature: The race to make COVID antibody therapies cheaper and more potent (Oct. 2020) Article • 2020 • NATURE Shares 4 topic signals

Remdesivir has ‘little or no effect’ in reducing coronavirus deaths, WHO says Article • 2020 • CNBC Shares 4 topic signals

U.S. pauses Eli Lilly's trial of a coronavirus antibody treatment over safety concerns Article • 2020 • CNBC Shares 4 topic signals

A Kid's Covid Vaccine Isn't Coming Anytime Soon - The New York Times Article • 2020 • NYTIMES Shares 4 topic signals

Synthetic biologists have created a slow-growing version of the coronavirus to give as a vaccine Article • 2020 • MIT Technology Review Shares 4 topic signals

Why Oxford’s positive COVID vaccine results are puzzling scientists

FoundryBase

Related resources

More from source

Found something worth adding?